Yao Hailu, Song Shiyong, Miao Xiaolu, Liu Xiao, Zhao Junli, Wang Zhen, Shao Xiaoting, Zhang Yu, Han Guang
Institute of Pharmacy, Pharmacy College of Henan University, Kaifeng, China.
Curr Drug Deliv. 2018;15(4):532-540. doi: 10.2174/1567201814666171120113521.
Many studies have shown that Andrographis paniculata (Burm. f.) Nees has a good anti-tumor effect, but poor solubility in water and poor bioavailability hinder the modernization of it.
To formulate the effective parts (mainly diterpene lactones) of Andrographis paniculata (AEP) into targeting drug delivery system, a series of poly(ethylene glycol)-poly(D.L-lactic acid)(mPEG-PLA) with different ratio of hydrophilic and hydrophobic segment was synthetized to encapsulate AEP. AEP micelles were prepared by a simple solvent-evaporation method. According to the loading capacity, the best polymer was chosen. mPEG-PLA micelles were characterized in terms of drug entrapping efficiency, loading capacity, size, the crystalline state of AEP, stability and release profile. Meanwhile, the cytotoxicity of micelles on mouse breast cancer 4T-1 was investigated.
These micelle (mPEG-PLA-AEP) particles had a size of (92.84±5.63) nm and a high entrapping efficiency and loading capacity of (91.00±11.53)% and (32.14±3.02)%(w/w), respectively. The powder DSC showed that drugs were well encapsulated in the core of micelles. mPEG-PLA-AEP had a good stability against salt dissociation, protein adsorption and anion substitution and the solubility of andrographolide (AG) and 14-deoxy-11,12-didehydroandrographolide(DDAG) in AEP increased 4.51 times and 2.12 times in water, and the solubility of DAG showed no difference. mPEG-PLA-AEP had the same release profile in different dissolution medium. Cytotoxicity testing in vitro demonstrated that mPEG-PLA-AEP exhibited higher cell viability inhibition in mouse breast cancer 4T-1 than free AEP.
mPEG-PLA micelles offer a promising alternative for TCM therapy with higher solubility and improved antitumor effect.
许多研究表明穿心莲具有良好的抗肿瘤作用,但水溶性差和生物利用度低阻碍了其现代化进程。
为将穿心莲有效部位(主要为二萜内酯)制成靶向给药系统,合成了一系列具有不同亲水疏水链段比例的聚乙二醇-聚(D,L-乳酸)(mPEG-PLA)用于包裹穿心莲有效部位。采用简单的溶剂挥发法制备穿心莲有效部位胶束。根据载药量选择最佳聚合物。对mPEG-PLA胶束的药物包封率、载药量、粒径、穿心莲有效部位的晶态、稳定性和释放曲线进行了表征。同时,研究了胶束对小鼠乳腺癌4T-1细胞的细胞毒性。
这些胶束(mPEG-PLA-AEP)颗粒粒径为(92.84±5.63)nm,包封率和载药量较高,分别为(91.00±11.53)%和(32.14±3.02)%(w/w)。粉末DSC表明药物被很好地包裹在胶束核心。mPEG-PLA-AEP对盐解离、蛋白质吸附和阴离子取代具有良好的稳定性,穿心莲内酯(AG)和14-去氧-11,12-二脱氢穿心莲内酯(DDAG)在穿心莲有效部位中的溶解度在水中分别提高了4.51倍和2.12倍,而脱水穿心莲内酯(DAG)的溶解度无差异。mPEG-PLA-AEP在不同溶出介质中的释放曲线相同。体外细胞毒性试验表明,mPEG-PLA-AEP对小鼠乳腺癌4T-1细胞的活力抑制作用高于游离穿心莲有效部位。
mPEG-PLA胶束具有更高的溶解度和更好的抗肿瘤效果,为中药治疗提供了一种有前景的选择。